A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Umkamin Tab in Acute Bronchitis Patients

Clinical trial NCT03654196 · COMPLETED

Trial details

NCT number: NCT03654196
Sponsor: Hanlim Pharm. Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Bronchitis

Start date: 2018-03-16
Primary completion: 2018-09-21
Enrollment: 246

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.